Daye
Bringing a new Daye in gynae health ☀️
United Kingdom
123 employees
Series A
Total: $15.50M
Biotechnology, Health Care +2
General Information
United Kingdom
BounceWatch is an independent company data service, not affiliated with Daye. To contact Daye, visit yourdaye.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Daye compare?
A PDF of Daye and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Daye soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United Kingdom Market
Biotechnology
About Daye
Business keywords: Gynecological Health, Feminine Health, Menstrual Health, Vaginal Microbiome, At-Home Screening, Menstrual Pain Relief, STI Detection, HPV Screening, Endometriosis Solutions, PCOS Management, Menopause Support, Digital Health Platform, Female Health Tech, Microbiome Testing, Health Monitoring
Services & Products
Target Customers
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | £10.00M | 6 |
|
26 Oct 2022 |
| Seed Round | $5.50M | 4 |
|
10 May 2019 |
| Non Equity Assistance | Undisclosed | 1 |
Google for Startups
|
01 Jan 2018 |
Latest News
View All
Daye Alternatives & Competitors
View All Alternatives
Kindra delivers clinically-backed, OBGYN-approved products to support vaginal and sexual health.
Empowering a billion people to manage their health with their mind, through effective and enjoyable...
FAQ About Daye
Source: BounceWatch company record for Daye, https://bouncewatch.com/company/daye, updated 25 March 2025. When citing, please name BounceWatch and link this page.
